Methods for modulating glycosylation of tislelizumab or its derivatives
TW202637214APending Publication Date: 2026-09-16BEONE MEDICINES I GMBH
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114149677
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-18
- Filing Date
- 2025-12-17
- Publication Date
- 2026-09-16
Smart Images
Figure TWG2TA001076811_001 
Figure TWG2TA001076811_002 
Figure TWG2TA001076811_003
Abstract
The present disclosure provides, among other things, methods of producing tislelizumab or its derivatives with reduced mannose glycosylation, tislelizumab or its derivatives produced by such methods, and tislelizumab or its derivatives comprising a mannose glycosylation level of less than about
Need to check novelty before this filing date? Find Prior Art